Cascade Investment Group’s Bio-Techne TECH Stock Holding History

Cascade Investment Group’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$209K	Hold	4,000	–	–	0.14%	136
2025 Q4	$235K	Hold	4,000	–	–	0.16%	126
2025 Q3	$223K	Hold	4,000	–	–	0.15%	133
2025 Q2	$206K	Hold	4,000	–	–	0.14%	136
2025 Q1	$235K	Hold	4,000	–	–	0.18%	116
2024 Q4	$288K	Hold	4,000	–	–	0.21%	110
2024 Q3	$320K	Hold	4,000	–	–	0.23%	94
2024 Q2	$287K	Hold	4,000	–	–	0.22%	102
2024 Q1	$282K	Hold	4,000	–	–	0.21%	111
2023 Q4	$309K	Hold	4,000	–	–	0.25%	94
2023 Q3	$272K	Hold	4,000	–	–	0.26%	87
2023 Q2	$327K	Hold	4,000	–	–	0.3%	85
2023 Q1	$297K	Hold	4,000	–	–	0.29%	90
2022 Q4	$332K	Buy	+4,000	New	+$318K	0.35%	80

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cascade Investment Group's TECH Position: Q1 2026 in Review

Cascade Investment Group held its Bio-Techne (TECH) position steady in Q1 2026 at 4,000 shares worth $209K. The position accounts for 0.14% of the portfolio, ranked #136.

Cascade Investment Group first reported a position in TECH in Q4 2022 and has held it in 14 quarters since. The position peaked at $332K in Q4 2022. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

Cascade Investment Group held 4,000 shares of Bio-Techne worth $209K as of Q1 2026.
Cascade Investment Group left its Bio-Techne share count unchanged in Q1 2026.
Bio-Techne made up 0.14% of Cascade Investment Group's portfolio in Q1 2026, its #136 holding.
Cascade Investment Group first reported a position in Bio-Techne in Q4 2022 and has held it in 14 quarters since.
Cascade Investment Group's Bio-Techne position peaked at $332K in Q4 2022.
582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Cascade Investment Group's 13F filing for Q1 2026, filed 13 May 2026.